Literature DB >> 33200741

Triggering factors for febrile attacks in Japanese patients with familial Mediterranean fever.

Dai Kishida1, Akinori Nakamura2, Masahide Yazaki3, Kenji Oka4, Ayako Tsuchiya-Suzuki5, Takanori Ichikawa5, Yasuhiro Shimojima5, Yoshiki Sekijima5.   

Abstract

OBJECTIVES: We occasionally encounter patients with familial Mediterranean fever (FMF) whose attacks are triggered by specific factors; however, information regarding these factors is limited. Our purpose was to identify the factors that trigger febrile attacks in Japanese patients with FMF.
METHODS: Our retrospective study included 372 patients (229 women, 143 men) with FMF, who were diagnosed between April 2007 and June 2018. We retrospectively investigated clinical features, genetic variants, and the factors that the patients perceived to have triggered their attacks. Patients completed a questionnaire that included the following triggering factors, anxiety, psychological stress, tiredness, excitement, environmental change, and menstruation.
RESULTS: Of 372 patients, 180 (49.4%) reported some triggering factors. Psychological stress and tiredness were commonly reported factors regardless of sex; however, menstruation (39.7%, n=91) was the most commonly reported triggering factor in female patients with FMF. Menstrual-related patients had a younger age of onset and diagnosis, a higher frequency of peritonitis, and a higher rate of patients with endometriosis compared with the non-menstrual-related patients.
CONCLUSIONS: Gaining an understanding of these triggering factors could help to reduce attacks and educate the patients. Clinicians may need to consider FMF for patients who have fever and serositis that occurs with every menstrual period.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33200741

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

1.  Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.

Authors:  Shiori Kinoshita; Hirokazu Komatsu; Haruna Fujinami; Takashi Yoshida; Tomotaka Suzuki; Tomoko Narita; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Shinsuke Iida
Journal:  Int J Hematol       Date:  2022-09-23       Impact factor: 2.319

Review 2.  The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.

Authors:  Eitan Giat; Ilan Ben-Zvi; Merav Lidar; Avi Livneh
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 3.  Interleukin-6 inhibition in the treatment of autoinflammatory diseases.

Authors:  Tomohiro Koga; Atsushi Kawakami
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.